This position paper describes the concerns of some Consortium members at the apparent policy differences emerging between different United Nations agencies, and individual member states, in the run up to the annual meeting of the UN agency responsible for oversight of the global drug control system. This meeting, held in Vienna in March, runs the risk of approving positions on Harm Reduction and Afghanistan that are at odds with the available evidence of what works in reducing drug problems.
- Epidemic Diary - ENPUD Information Digest
- INPUD online survey on COVID-19 and people who use drugs data report
- Cost-effective tools to reduce the spread of the hepatitis C virus in people who inject drugs
- Reorienting drug policy in Indonesia: Pathways to the Sustainable Development Goals
- EMCDDA trendspotter briefing: Impact of COVID-19 on patterns of drug use and drug-related harms in Europe
- Cannabis rescheduling: What could it mean for Africa?
- Harm reduction for women in prisons
- Barriers to harm reduction for women who use drugs in South Africa
- Interruption and Innovation - The impact of policy measures during the COVID-19 pandemic on key and vulnerable populations for HIV, tuberculosis and viral hepatitis in Eastern Europe and Central Asia